Patents by Inventor Masahiro Murata
Masahiro Murata has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20120194871Abstract: An image processing device adjusts black separately from chromatic colors and applies density adjustment capable of controlling the amount of color material according to the density. Such image processing device, capable of communicating with an image recording device, includes a color conversion unit that converts image data expressed in a first color space to color material amount data expressed in a second color space used by an image recording device; a density adjustment unit that increases or decreases the color material amount data based on a specified adjustment value; a dot breakdown unit that converts the increased or decreased color material amount data to dot quantity data expressed as a dot quantity for each of different sizes of dots formed by the image recording device; and a halftone process unit that converts the dot quantity data to data denoting whether or not the dots are formed.Type: ApplicationFiled: January 27, 2012Publication date: August 2, 2012Applicant: SEIKO EPSON CORPORATIONInventor: Masahiro Murata
-
Patent number: 8222405Abstract: Specified phenylalanine derivatives and analogues thereof have an antagonistic activity to ?4 integrin. They are used as therapeutic agents for various diseases concerning ?4 integrin.Type: GrantFiled: November 22, 2010Date of Patent: July 17, 2012Assignee: Ajinomoto Co., Inc.Inventors: Shingo Makino, Tatsuya Okuzumi, Toshihiko Yoshimura, Yuko Satake, Nobuyasu Suzuki, Hiroyuki Izawa, Kazuyuki Sagi, Akira Chiba, Eiji Nakanishi, Masahiro Murata, Takashi Tsuji
-
Patent number: 8168827Abstract: Amide derivatives represented by the formula (I): wherein: A is a cycloalkyl group, an aryl group or a heteroaryl group; X is a nitrogen atom or CR17; Y is —NRa-, —(CRbRb?)m-, and the like; m is 0 to 4; and R1 to R17 may be the same or different and each is a hydrogen atom, a halogen atom, a cyano group, a nitro group, a carboxyl group, a formyl group, a hydroxyl group, an ammonium group, an alkyl group optionally having one or more substituents, -ZR18 and the like, Z is —O—, —S(O)p-, —S(O)pO—, —NH—, —NR19-, and the like; or a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof may be applied to pharmaceutical use such as anti-inflammatory and analgesic action and the like.Type: GrantFiled: June 19, 2009Date of Patent: May 1, 2012Assignee: Ajinomoto Co., Inc.Inventors: Tadakiyo Nakagawa, Tamotsu Suzuki, Kaoru Takenaka, Shinichi Fujita, Youji Yamada, Yoichiro Shima, Tatsuya Okuzumi, Toshihiko Yoshimura, Masanao Yoshida, Masahiro Murata
-
Patent number: 8012599Abstract: The surface-treated steel sheet has a zinc-based plated steel sheet, a surface-treatment coating being formed on the surface of the zinc-based steel sheet by applying and drying a surface treatment coating composition thereon, and a top coating being formed by applying and drying a coating composition for top coating on the surface-treatment coating. The surface treatment coating composition contains a water-epoxy resin dispersion, a silane coupling agent, and phosphoric acid and/or a hexafluorometal acid. The coating composition for top coating contains a high molecular weight epoxy group-containing resin having number average molecular weights ranging from 6000 to 20000.Type: GrantFiled: October 26, 2007Date of Patent: September 6, 2011Assignees: JFE Steel Corporation, Kansai Paint Co., Ltd.Inventors: Tatsuya Miyoshi, Kenichi Sasaki, Naoto Yoshimi, Akira Matsuzaki, Kazuhisa Okai, Takao Ooshima, Takashi Nakano, Masahiro Murata, Syoichi Tanaka
-
Publication number: 20110065918Abstract: Specified phenylalanine derivatives and analogues thereof have an antagonistic activity to ?4 integrin. They are used as therapeutic agents for various diseases concerning ?4 integrin.Type: ApplicationFiled: November 22, 2010Publication date: March 17, 2011Applicant: Ajinomoto Co., Inc.Inventors: Shingo MAKINO, Tatsuya Okuzumi, Toshihiko Yoshimura, Yuko Satake, Nobuyasu Suzuki, Hiroyuki Izawa, Kazuyuki Sagi, Akira Chiba, Eiji Nakanishi, Masahiro Murata, Takashi Tsuji
-
Patent number: 7902179Abstract: A pharmaceutical composition containing a heterocyclic compound of the formula (I) wherein each symbol is as defined in the specification, an isomer thereof, a solvate thereof or a pharmaceutically acceptable salt thereof as an active ingredient has a superior TNF-? production suppressing action. Accordingly, it is useful for the prophylaxis or treatment of various diseases caused by abnormal production of TNF-?.Type: GrantFiled: April 26, 2002Date of Patent: March 8, 2011Assignee: Ajinomoto Co., Inc.Inventors: Yasuhiro Tanaka, Kohichi Fujita, Yoshitomo Chujoh, Syunsuke Fukuda, Yuka Ikenoue, Tomoyuki Tagami, Akira Chiba, Ariko Kodaira, Hideki Matsumoto, Tadakiyo Nakagawa, Tatsuhiro Yamada, Manabu Suzuki, Masahiro Murata
-
Patent number: 7884204Abstract: Phenylalanine derivatives of the following formula, analogues thereof and pharmaceutically acceptable salts thereof have an antagonistic activity to ?4 integrin. They are used as therapeutic agents or preventive agents for various diseases concerning ?4 integrin in which ?4 integrin-depending adhesion process participates in the pathology, such as inflammatory diseases, rheumatoid arthritis, inflammatory bowel diseases, systemic lupus erythematosus, multiple sclerosis, Sjögren's syndrome, asthma, psoriasis, allergy, diabetes, cardiovascular diseases, arterial sclerosis, restenosis, tumor proliferation, tumor metastasis and transplantation rejection. wherein R1 is a methyl group and R2 is a methoxy group.Type: GrantFiled: June 25, 2007Date of Patent: February 8, 2011Assignee: Ajinomoto Co., Inc.Inventors: Tatsuya Okuzumi, Kazuyuki Sagi, Toshihiko Yoshimura, Yuji Tanaka, Eiji Nakanishi, Miho Ono, Masahiro Murata
-
Patent number: 7872125Abstract: Specified phenylalanine derivatives and analogues thereof have an antagonistic activity to ?4 integrin. They are used as therapeutic agents for various diseases concerning ?4 integrin.Type: GrantFiled: May 30, 2006Date of Patent: January 18, 2011Assignee: Ajinomoto Co., Inc.Inventors: Shingo Makino, Tatsuya Okuzumi, Toshihiko Yoshimura, Yuko Satake, Nobuyasu Suzuki, Hiroyuki Izawa, Kazuyuki Sagi, Akira Chiba, Eiji Nakanishi, Masahiro Murata, Takashi Tsuji
-
Patent number: 7842902Abstract: A method of carrying out laser processing along processing lines having linear portions and curved portions formed on a workpiece by using a laser beam processing machine comprising a laser beam application means for applying a laser beam to the workpiece held on a chuck table which comprises a condenser for converging a laser beam, having a focal spot changing means for changing the shape of a focal spot between an elliptic spot and a circular spot, comprising the steps of: moving a processing line formed on the workpiece to the application position of a laser beam, activating the focal spot changing means to make an elliptic focal spot and positioning the long axis of the elliptic spot along a linear portion of the processing line when the linear portion of the processing line is located at the application position of the laser beam and activating the focal spot changing means to make a circular focal spot when a curved portion of the processing line is located at the application position of the laser beam.Type: GrantFiled: September 10, 2007Date of Patent: November 30, 2010Assignee: Disco CorporationInventors: Masahiro Murata, Hiroshi Morikazu
-
Publication number: 20100253955Abstract: A recording control device can adjust the recording density without causing color shifting when recording images using chromatic and achromatic inks. A host computer 2 is connected to a printer 3 that records on a recording medium using the four ink colors CMYK, and has a printer driver 10 that converts an image to be recorded to ink volume values using a lookup table for converting coordinate values of an input color model to ink volume values in a CMYK ink color model, and causes the printer 3 to record the image to be recorded according to this ink volume information. When the black dot recording density for parts that are printed on the recording medium using black and the color recording density of parts that are printed a chromatic color are set, the printer driver 10 generates a new lookup table based on these set density values and values in a lookup table, and causes the printer 3 to print based on the resulting new lookup table.Type: ApplicationFiled: March 31, 2010Publication date: October 7, 2010Applicant: SEIKO EPSON CORPORATIONInventor: Masahiro Murata
-
Publication number: 20100245867Abstract: An image processing device, an image processing method, and a program enable easily acquiring for each profile information related to the amount of ink that is required to record image data after the image data is converted using a particular profile. A host computer 1 transforms reference image data 27 based on an ICC profile 23 for transforming image data to image data in a different color space, and outputs transformed reference image data 28. Based on a lookup table 25 for transforming the coordinate values of a color space to ink volume information in an ink color space rendered by plural different types of ink, the transformed reference image data 28 is converted to ink volume information, and based on this ink volume information and the reference image data 27 before the transformation, ink information correlating the ink volume information to the colors contained in the reference image data 27 before transformation is produced.Type: ApplicationFiled: March 23, 2010Publication date: September 30, 2010Applicant: SEIKO EPSON CORPORATIONInventor: Masahiro Murata
-
Patent number: 7759388Abstract: Specific phenylalanine derivatives or pharmaceutically acceptable salts thereof have an antagonistic effect on the ? 4 integrins and, therefore, are usable as therapeutic agents or preventive agents for diseases in which ? 4 integrin-depending adhesion process participates in the pathology, such as inflammatory diseases, rheumatoid arthritis, inflammatory bowel diseases, systemic lupus erythematosus, multiple sclerosis, Sjögren's syndrome, asthma, psoriasis, allergy, diabetes, cardiovascular diseases, arterial sclerosis, restenosis, tumor proliferation, tumor metastasis and transplantation rejection.Type: GrantFiled: October 16, 2008Date of Patent: July 20, 2010Assignee: Ajinomoto Co., Inc.Inventors: Nobuyasu Suzuki, Toshihiko Yoshimura, Hiroyuki Izawa, Kazuyuki Sagi, Shingo Makino, Eiji Nakanishi, Masahiro Murata, Takashi Tsuji
-
Patent number: 7605165Abstract: The present invention relates to the following phenylalanine derivatives or analogues thereof having an antagonistic activity to ?4 integrin and therapeutic agents for various diseases concerning ?4 integrin.Type: GrantFiled: August 20, 2004Date of Patent: October 20, 2009Assignee: Ajinomoto Co., Inc.Inventors: Kazuyuki Sagi, Hiroyuki Izawa, Akira Chiba, Tatsuya Okuzumi, Toshihiko Yoshimura, Yuji Tanaka, Miho Ono, Masahiro Murata
-
Publication number: 20090258900Abstract: Amide derivatives represented by the formula (I): wherein: A is a cycloalkyl group, an aryl group or a heteroaryl group; X is a nitrogen atom or CR17; Y is —NRa—, —(CRbRb?)m-, and the like; m is 0 to 4; and R1 to R17 may be the same or different and each is a hydrogen atom, a halogen atom, a cyano group, a nitro group, a carboxyl group, a formyl group, a hydroxyl group, an ammonium group, an alkyl group optionally having one or more substituents, -ZR18 and the like, Z is —O—, —S(O)p-, —S(O)pO—, —NH—, —NR19-, and the like; or a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof may be applied to pharmaceutical use such as anti-inflammatory and analgesic action and the like.Type: ApplicationFiled: June 19, 2009Publication date: October 15, 2009Applicant: AJINOMOTO CO. INCInventors: Tadakiyo Nakagawa, Tamotsu Suzuki, Kaoru Takenaka, Shinichi Fujita, Youji Yamada, Yoichiro Shima, Tatsuya Okuzumi, Toshihiko Yoshimura, Masanao Yoshida, Masahiro Murata
-
Patent number: 7572815Abstract: Amide derivatives represented by the formula (I): wherein: A is a cycloalkyl group, an aryl group or a heteroaryl group; X is a nitrogen atom or CR17; Y is —NRa—, —(CRbRb?)m-, and the like; m is 0 to 4; and R1 to R17 may be the same or different and each is a hydrogen atom, a halogen atom, a cyano group, a nitro group, a carboxyl group, a formyl group, a hydroxyl group, an ammonium group, an alkyl group optionally having one or more substituents, ZR18 and the like, Z is —O—, —S(O)p-, —S(O)pO—, —NH—, —NR19-, and the like; or R1 and R2 may in combination form a ring, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof may be applied to pharmaceutical use such as anti-inflammatory and analgesic action and the like.Type: GrantFiled: November 18, 2005Date of Patent: August 11, 2009Assignee: Ajinomoto Co., Inc.Inventors: Tadakiyo Nakagawa, Tamotsu Suzuki, Kaoru Takenaka, Shinichi Fujita, Youji Yamada, Yoichiro Shima, Tatsuya Okuzumi, Toshihiko Yoshimura, Masanao Yoshida, Masahiro Murata
-
Kit for determining polysaccharide-binding activity of mononuclear cells present in peripheral blood
Patent number: 7553824Abstract: A kit for the determination of the ability of a peripheral blood mononuclear cell to bind to a polysaccharide herein provided comprises a detection reagent comprising a fluorescence-labeled immunostimulant polysaccharide; and a reference reagent comprising a fluorescence-labeled material of a polysaccharide different from that used in the fluorescence-labeled immunostimulant polysaccharide, and/or an immunostimulant polysaccharide which is not labeled with any fluorescent material and whose polysaccharide moiety is identical to that included in the fluorescence-labeled immunostimulant polysaccharide. The use of this kit would permit the estimation of the polysaccharide-binding ability of a peripheral blood mononuclear cell in a higher precision of estimation.Type: GrantFiled: May 9, 2008Date of Patent: June 30, 2009Assignee: Ajinomoto Co., Inc.Inventors: Tetsuya Suga, Yasuyo Suga, Masahiro Murata -
Patent number: 7517591Abstract: The surface-treated steel sheet has a zinc-based plated steel sheet, a surface-treatment coating being formed on the surface of the zinc-based steel sheet by applying and drying a surface treatment coating composition thereon, and a top coating being formed by applying and drying a coating composition for top coating on the surface-treatment coating. The surface treatment coating composition contains a water-epoxy resin dispersion, a silane coupling agent, and phosphoric acid and/or a hexafluorometal acid. The coating composition for top coating contains a high molecular weight epoxy group-containing resin having number average molecular weights ranging from 6000 to 20000.Type: GrantFiled: June 14, 2004Date of Patent: April 14, 2009Assignees: JFE Steel Corporation, Kansai Paint Co., Ltd.Inventors: Tatsuya Miyoshi, Kenichi Sasaki, Naoto Yoshimi, Akira Matsuzaki, Kazuhisa Okai, Takao Ooshima, Takashi Nakano, Masahiro Murata, Syoichi Tanaka
-
Publication number: 20090048236Abstract: Specific phenylalanine derivatives or pharmaceutically acceptable salts thereof have an antagonistic effect on the ?4 integrins and, therefore, are usable as therapeutic agents or preventive agents for diseases in which ?4 integrin-depending adhesion process participates in the pathology, such as inflammatory diseases, rheumatoid arthritis, inflammatory bowel diseases, systemic lupus erythematosus, multiple sclerosis, Sjögren's syndrome, asthma, psoriasis, allergy, diabetes, cardiovascular diseases, arterial sclerosis, restenosis, tumor proliferation, tumor metastasis and transplantation rejection.Type: ApplicationFiled: October 16, 2008Publication date: February 19, 2009Applicant: AJINOMOTO CO. INCInventors: Nobuyasu SUZUKI, Toshihiko Yoshimura, Hiroyuki Izawa, Kazuyuki Sagi, Shingo Makino, Eiji Nakanishi, Masahiro Murata, Takashi Tsuji
-
Patent number: 7452905Abstract: Specific phenylalanine derivatives or pharmaceutically acceptable salts thereof have an antagonistic effect on the ? 4 integrins and, therefore, are usable as therapeutic agents or preventive agents for diseases in which ? 4 integrin-depending adhesion process participates in the pathology, such as inflammatory diseases, rheumatoid arthritis, inflammatory bowel diseases, systemic lupus erythematosus, multiple sclerosis, Sjögren's syndrome, asthma, psoriasis, allergy, diabetes, cardiovascular diseases, arterial sclerosis, restenosis, tumor proliferation, tumor metastasis and transplantation rejection.Type: GrantFiled: March 31, 2003Date of Patent: November 18, 2008Assignee: Ajinomoto Co., Inc.Inventors: Nobuyasu Suzuki, Toshihiko Yoshimura, Eiji Nakanishi, Masahiro Murata, Takashi Tsuji
-
Publication number: 20080280909Abstract: Phenylalanine derivatives of the following formula, analogues thereof and pharmaceutically acceptable salts thereof have an antagonistic activity to ?4 integrin. They are used as therapeutic agents or preventive agents for various diseases concerning ?4 integrin in which ?4 integrin-depending adhesion process participates in the pathology, such as inflammatory diseases, rheumatoid arthritis, inflammatory bowel diseases, systemic lupus erythematosus, multiple sclerosis, Sjögren's syndrome, asthma, psoriasis, allergy, diabetes, cardiovascular diseases, arterial sclerosis, restenosis, tumor proliferation, tumor metastasis and transplantation rejection. wherein R1 is a methyl group and R2 is a methoxy group.Type: ApplicationFiled: June 25, 2007Publication date: November 13, 2008Applicant: Ajinomoto Co., Inc.Inventors: Tatsuya Okuzumi, Kazuyuki Sagi, Toshihiko Yoshimura, Yuji Tanaka, Eiji Nakanishi, Miho Ono, Masahiro Murata